C18 vs C8 vs C4 Columns for Peptide Purification

C18 is the most common starting stationary phase for reversed-phase peptide purification, but it is not always the best choice. For routine synthetic peptides, C18 generally provides sufficient retention, good peak focusing and straightforward transfer from analytical to preparative scale. Problems arise when strong retention causes broad peaks, tailing, carry-over or poor recovery, particularly with hydrophobic, lipidated or long peptide sequences.

In these cases, changing from C18 to C8 or C4 can be more effective than simply extending the gradient. Stationary-phase chemistry affects not only retention time, but also the selectivity between the target peptide and structurally related impurities.

This distinction is important in practical peptide purification and quality control, where the objective is not simply to retain a peptide strongly, but to recover enough correctly identified material at the required purity.

C18, C8 and C4: What Actually Changes?

C18, C8 and C4 are reversed-phase bonded stationary phases with progressively shorter hydrocarbon ligands. C18 generally provides the strongest hydrophobic interaction, C8 is intermediate, and C4 provides lower retention.

This ranking is useful, but ligand length alone does not determine chromatographic performance. Ligand density, pore size, surface chemistry, particle structure, mobile phase, temperature and peptide conformation can all influence the final separation.

Two C18 columns can therefore generate different impurity profiles, while switching from C18 to C8 may change the relative spacing between two peptide peaks rather than simply making both elute earlier.

Alan Scientific View: the stationary phase should be selected according to the impurity that limits purification, not according to peptide retention alone. If a critical impurity remains adjacent to the target on C18, making the gradient progressively longer may increase run time without solving the underlying selectivity problem.

Figure 1. C18, C8 and C4 bonded-phase interaction. Shorter alkyl ligands generally reduce hydrophobic retention, but changing stationary-phase chemistry can also alter selectivity between a target peptide and related impurities.

Published Data: Hydrophobic Peptides Can Behave Very Differently on C18 and C4

A useful example was reported by Kristensen and colleagues in Analytical Chemistry in 2022. During LC-MS peptide mapping, several highly hydrophobic peptides showed substantial tailing and carry-over on conventional C18 stationary phases. The investigators evaluated lower-retentivity C4 chemistry rather than relying only on further gradient adjustment.

For three USP mAb3 peptides using Accucore columns, the reported carry-over was:

For peptide L60–103, carry-over decreased from 12.50% on C18 to 0.08% on C4, a reduction of more than 150-fold. The other two hydrophobic peptides showed the same general trend.

The study was designed for analytical peptide mapping rather than preparative peptide purification, so these values should not be interpreted as preparative recovery data. The underlying chromatographic lesson is nevertheless important: when peptide interaction with a stationary phase becomes excessive, changing the chemistry can address a problem that a longer C18 gradient may not solve.

Figure 2. Published carry-over data for three hydrophobic peptides separated using Accucore C4 and C18 stationary phases. Data adapted from Kristensen et al., Analytical Chemistry, 2022. Values represent analytical carry-over measured in subsequent blank injections.

C8 Is Often More Useful Than a Simple “Middle Option”

C8 is sometimes described as nothing more than a less-retentive C18 phase. In practical method development, it can be much more useful than that description suggests.

A comparative study of C18, C8 and C4 monolithic silica columns for peptide and protein separations found differences in chromatographic efficiency across the three bonded phases. Under the conditions tested, C8 provided the best overall balance when resolution, gradient time, flow rate and solvent consumption were considered together.

This is an important result because it demonstrates why column selection cannot be reduced to a ranking of hydrophobic strength.

C4 does not automatically become the best phase because it provides the lowest retention, just as C18 does not automatically become the best because it provides the strongest retention.

For moderately hydrophobic peptides that show excessive C18 interaction, C8 can provide enough retention for good chromatographic focusing while changing the target-to-impurity selectivity.

For difficult custom peptide synthesis projects, screening C8 early can therefore be more efficient than repeatedly modifying the same C18 method.

Pore Size Can Matter as Much as Bonded-Phase Chemistry

The terms C18, C8 and C4 describe bonded ligand chemistry. They do not describe pore size.

A conventional C18 column with approximately 100 to 130 Å pores and a wide-pore C18 column around 300 Å can behave differently even though both are marketed as C18.

As peptide size increases, access to the internal surface of chromatographic particles becomes increasingly important. Wide-pore phases are commonly used for larger peptides and biomolecules because the larger pore structure improves accessibility.

This does not mean that 300 Å material is automatically superior for every peptide. Wider pores generally provide improved accessibility for larger molecules, while smaller pores can provide greater total surface area.

Peptide size, conformation, hydrophobicity and mass loading should therefore be evaluated together.

This is also why a difficult C18 separation should not immediately trigger a switch to C8 or C4. In some cases, moving from a conventional-pore C18 column to a wide-pore C18 column may be the more rational experiment.

Analytical Resolution Does Not Guarantee Preparative Performance

An analytical chromatogram is generated at relatively low sample loading. During preparative purification, substantially more crude peptide must be introduced onto the stationary phase.

As loading increases, peaks broaden and separation between the target and neighboring impurities can deteriorate. Sample solvent can further complicate the result. Hydrophobic peptides may require significant organic solvent, DMSO or other strong solvents for dissolution, and injecting a sample that is much stronger than the starting mobile phase can cause poor focusing, peak fronting or splitting.

A method that appears to have weak stationary-phase selectivity may therefore sometimes be suffering from an injection-solvent problem.

This is why RP-HPLC method development and scale-up should evaluate crude profile, gradient, loading and sample conditions together rather than treating the column as an isolated variable.

For preparative work, useful performance metrics include final fraction purity, recovered peptide quantity, acceptable mass loading, number of injections and the need for repurification.

The requested peptide purity also matters. A method sufficient for a 95% specification may require much more conservative fraction pooling to achieve 98% or higher purity, reducing recovery even when the chromatographic profile itself has not changed.

Alan Scientific View: the best analytical chromatogram is not necessarily the best preparative process. The more meaningful metric is the amount of peptide meeting specification that can be recovered with acceptable solvent use, instrument time and peptide loss.

Practical Selection by Peptide Type

Lipidated peptides are a particularly clear example. Addition of a fatty acid can significantly increase retention compared with the parent sequence, so a C18 method developed for the unmodified peptide may no longer be appropriate.

Fluorescent labeling can create a similar effect. FITC, Cy5 and other aromatic fluorophores can substantially alter peptide hydrophobicity and may introduce additional species such as unlabeled peptide or modification-related impurities.

Cyclic peptides can also behave differently from their linear precursors because cyclization changes peptide conformation and exposed hydrophobic surface.

These projects often require column selection to be treated as part of method development rather than as a fixed production parameter.

Purification Economics: The Cheapest Column Is Not Always the Lowest-Cost Method

Column purchase price is easy to compare, but it is rarely the most useful measure of peptide purification cost.

A more complete calculation includes column lifetime, acetonitrile consumption, number of injections, fraction analysis, operator time, target recovery and whether the peptide requires a second purification cycle.

Consider a difficult peptide where one phase produces slightly better selectivity around the critical impurity. That improvement may allow broader fraction pooling and eliminate repurification.

The financial value of that improvement can be much greater than the difference in column price.

This becomes particularly important for expensive peptides containing non-natural amino acids, isotope-labeled residues, lipid groups, fluorescent labels or other costly modifications. Losing material during purification can represent substantially more cost than the chromatography itself.

Final peptide quality control, including analytical HPLC and mass spectrometry, should therefore be considered part of the purification workflow rather than a completely separate final step.

A successful method is one that converts crude peptide into sufficient specification-compliant material with reproducible purity and identity.

Conclusion

C18 remains the logical starting phase for many synthetic peptide separations, but it should be treated as a starting point rather than a universal rule.

Published data demonstrate that highly hydrophobic peptides can behave dramatically differently on C18 and C4, while comparative stationary-phase studies show that C8 can provide an effective balance between retention and chromatographic performance.

The most useful question is therefore not which column provides the strongest peptide retention.

It is whether the stationary phase creates enough selectivity between the target and the critical impurity to achieve the required purity at practical loading and acceptable recovery.

Alan Scientific View: for preparative peptide purification, stationary-phase selection is ultimately a process-development decision. The best column is the one that produces the required peptide specification with the highest practical recovery and the lowest total process burden.

Researchers developing challenging peptide projects can explore Alan Scientific's custom peptide synthesis and purification services, including peptide purification and HPLC/MS-based analytical characterization.

References

1. Kristensen DB, et al. Optimized Multi-Attribute Method Workflow Addressing Missed Cleavages and Chromatographic Tailing/Carry-Over of Hydrophobic Peptides. Analytical Chemistry. 2022;94:17195–17204.

2. Skudas R, et al. Impact of pore structural parameters on column performance and resolution of reversed-phase monolithic silica columns for peptides and proteins. Journal of Chromatography A. 2007;1144:72–84.

3. Waters Corporation. Technical guidance on reversed-phase pore-size and stationary-phase selection for peptide and biomolecule separations.